Holding(s) in Company

RNS Number : 9350P
Allergy Therapeutics PLC
01 April 2009
 





TR-1: Notifications of Major Interests in Shares



1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Allergy Therapeutics plc


2. Reason for notification (yes/no)


An acquisition or disposal of voting rights

Yes


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:

Mr C Moreno


4. Full name of shareholder(s) (if different from 3):

N/A


5. Date of transaction (and date on which the threshold is crossed or reached if different):

23/03/09


6. Date on which issuer notified:

30/03/09


7. Threshold(s) that is/are crossed or reached:

7%




8: Notified Details
A: Voting rights attached to shares
 
Class/type of shares
If possible use ISIN code
Situation previous to the triggering transaction
Resulting situation after the triggering transaction
Number of shares
Number of voting rights
Number of shares
Number of voting rights
Percentage of voting rights
 
Direct
 
Indirect
 
Direct
 
Indirect
GB00B02LLQ05
3,449,033     
3,449,033             
5,882,458       
   5,882,458
 
7.1%
 


 

B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A








Total (A+B)


Number of voting rights

Percentage of voting rights

5,882,458

7.1%


 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:



Proxy Voting:


10. Name of proxy holder:


N/A

11. Number of voting rights proxy holder will cease to hold:



12. Date on which proxy holder will cease to hold voting rights:




13. Additional information:



14 Contact name:



15. Contact telephone name:





This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAUORKURSRAR
UK 100

Latest directors dealings